Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | JANX007 |
Trade Name | |
Synonyms | JANX-007|JANX 007 |
Drug Descriptions |
JANX007 is a trispecific tumor-associated T-cell engager containing binding domains for PSMA, CD3, and albumin, as well as a CD3 inhibitory peptide mask, which potentially leads to enhanced antitumor immune response (Journal for ImmunoTherapy of Cancer 2022;10). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C190729 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
JANX007 | JANX007 | 0 | 1 |